MDA-7/IL-24 as a cancer therapeutic: from bench to bedside
Liposomal cisplatin: a new cisplatin formulation
Targeted therapy in advanced colorectal cancer: more data, more questions
Systematic review of benefits and risks of second-line irinotecan monotherapy for advanced colorectal cancer
Chimeric tyrosine kinase-HDAC inhibitors as antiproliferative agents
Evodiamine induces caspase-dependent apoptosis and S phase arrest in human colon lovo cells
A phase I/II and pharmacogenomic study of pemetrexed and cisplatin in patients with unresectable, advanced gastric carcinoma
Phase I trial of weekly irinotecan and paclitaxel combined with carboplatin in patients with advanced cancer: a Hellenic Cooperative Oncology Group Study
Successful dexrazoxane treatment of a potentially severe extravasation of concentrated doxorubicin
Response to trabectedin treatment in a highly pretreated patient with an advanced meningeal hemangiopericytoma